ScreenerHero

BYSI BeyondSpring Inc.

NAS · US · Healthcare · Biotechnology · beyondspringpharma.com
0.6445USD-6.90%Mkt Cap: 26.50M $P/E: —

BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: t…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap26.50M USD
Enterprise Value21.65M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-1.01M USD
Revenue/Share—
Last Price0.6445 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees44
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.47
PEG—
EV/EBITDA-2.58
EV/Revenue—
P/S—
P/B-0.80
EPS (TTM)-0.18
EPS (Forward)-0.47
52W Range
0.57004% of range2.440
52W High2.440 USD
52W Low0.5700 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE3.13%
ROA-3.88%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.77M USD
CapEx (TTM)50.00K USD
FCF Margin—
FCF Yield40.30%
Net Debt-6.36M USD
Net Debt/EBITDA0.76
Balance Sheet
Debt/Equity-0.01
Current Ratio0.70
Quick Ratio0.46
Book Value/Sh-0.86 USD
Cash/Share0.16 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.41.12M
Float31.95M
Insiders17.40%
Institutions14.80%
Short Interest
Short Ratio19.0d
Short % Float6.70%
Short % Out.5.55%
Shares Short2.28M
Short (prev mo.)2.73M
Technical
SMA 500.8025 (-19.7%)
SMA 2001.386 (-53.5%)
Beta-0.21
S&P 52W Chg16.45%
Avg Vol (30d)287.90K
Avg Vol (10d)1.12M
Technical Indicators
RSI (14)41.1
MACD-0.0278
MACD Signal-0.0281
MACD Hist.+0.0002
BB Upper0.9581 USD
BB Middle0.7568 USD
BB Lower0.5556 USD
BB Width53.18%
ATR (14)0.1156 USD
Vol Ratio (20d)0.26x